Shareholder Activities
2018-2019 NWCRI Shareholder Activities
NWCRI members are bringing 16 justice issues to the boardrooms of 46 corporations, filing 31 shareholder resolutions* and participating in over 40 dialogues.
| Company | Issue |
|
| AbbVie | Board Oversight – Risks Related to Opioid Crisis |
|
| AbbVie | Senior Executive Incentives – Integrate Drug Pricing Risk |
|
| AbbVie | Global Health |
|
| Altria Group* | Reducing Nicotine to Less Addictive Level |
|
| Amazon* | Risks of Sales of Facial Recognition Software |
|
| Amazon | Identifying Human Rights Risks in Operations/Supply Chain |
|
| American Outdoors Brands | Develop a Human Rights Policy |
|
| American Outdoors Brands | Prohibit Virtual-Only-AGM | Resolution |
| Amerisource Bergen* | Board Oversight – Risks Related to Opioid Crisis | Resolution W/drawn |
| Amgen | Senior Executive Incentives – Integrate Drug Pricing Risk |
|
| Archer Daniels Midland | Human Rights Due diligence/Water Stewardship |
|
| Biogen | Senior Executive Incentives – Integrate Drug Pricing Risk |
|
| Bristol-Myers Squibb | Senior Executive Incentives – Integrate Drug Pricing Risk |
|
| Bristol-Myers Squibb | Global Health |
|
| Campbell Soup | Health Outcomes Related to Diet/Human Right to Water |
|
| Cardinal Health | Board Oversight – Risks Related to Opioid Crisis |
|
| Caterpillar | Business Activities in Conflict-Affected Areas |
|
| Chevron | Human Right to Water |
|
| Coca-Cola | Water Stewardship/Sustainable Agriculture |
|
| CoreCivic | Private Prisons/Human Rights Due Diligence |
|
| CVS Health | Board Oversight – Risks Related to Opioid Crisis |
|
| CVS Health | Pharmacy Benefit Manager – Influence on Drug Pricing |
|
| Disney* | Lobbying Expenditures Disclosure – Climate |
|
| Dollar Tree Stores* | Sustainability Reporting |
|
| DowDuPont | Grower Compliance for GMOs |
|
| Duke Energy* | Lobbying Expenditures Disclosure |
|
| ExxonMobil | Greenhouse Gas Reduction – In Line with Paris Goals |
|
| ExxonMobil | Independent Board Chair |
|
| Independent Board Chair |
|
|
| Freeport McMoRan | Human Rights Supplier Standards |
|
| General Mills | Health Outcomes Related to Diet |
|
| GEO Group | Human Rights Policy Implementation & Performance |
Resolution
|
| Gilead Sciences | Drug Pricing/Global Health |
|
| Hershey | Human Rights Due Diligence |
|
| Johnson & Johnson | Global Health |
|
| Johnson & Johnson | Anti-Competitive Practices |
|
| JP Morgan Chase | Immigration – Human Rights Due Diligence |
|
| JP Morgan Chase* | Lobbying Expenditures Disclosure – Climate | Resolution W/drawn |
| Kraft Heinz | Human Rights Due Diligence |
|
| Kroger | Human Rights Due Diligence |
|
| Macy’s* | Human Rights Due Diligence |
|
| McDonald’s | Health Outcomes Related to Diet |
|
| McDonald’s | Phase Out Medically Important Antibiotics | Resolution |
| Merck | Global Health |
|
| Merck | Senior Executive Incentives – Integrate Drug Pricing Risk |
|
| Newmont Mining | Human Rights Supplier Standards |
|
| Northrop Grumman* | Immigration – Human Rights Due Diligence |
|
| PepsiCo | Water/Reduce Pesticide/Pollinator Health |
|
| Pfizer | Board Oversight – Drug Pricing |
|
| Pfizer | Global Health |
|
| Pfizer | Senior Executive Incentives-Integrate Drug Pricing Risk |
|
| Pfizer* | Independent Chair |
|
| Philip Morris* | Review Corporate Adherence to Youth Marketing Principles |
|
| Sanofi | Global Health/Drug Pricing |
|
| Sturm Ruger | Adopt Proxy Access Bylaw |
|
| Sturm Ruger | Develop a Human Rights Policy |
|
| Tyson Foods | Human Rights Due Diligence |
|
| United Health | Pharmacy Benefit Manager – Influence on Drug Pricing |
|
| UPS* | Lobbying Expenditures Disclosure – Climate |
|
| Walgreens Boot Alliance | Board Oversight – Risks Related to Opioid Crisis |
|
| Walmart | Adequate Health Insurance for Employees |
|
| Walmart | Human Rights Supplier Standards |
|
| Wells Fargo | Business Standards/Vision & Values/Risk Management |
|
*Includes resolutions filed by the Sisters of St. Francis of Philadelphia out of their office